Clinical trial
Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors
NCT00006018 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006018 |
|---|---|
| Title | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of BMS-214662 and Paclitaxel in Patients With Advanced Malignancies |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BMS-214662, paclitaxel |
| Enrollment | 5 |
| Start date | Jul 1, 2000 |
| Primary completion | Dec 1, 2001 |
| Completion | Apr 1, 2002 |
| First posted | Mar 8, 2004 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: